iShares Biotechnology ETF $IBB Shares Sold by Westwood Wealth Management

Westwood Wealth Management lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 49.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,880 shares of the financial services provider’s stock after selling 6,760 shares during the quarter. Westwood Wealth Management’s holdings in iShares Biotechnology ETF were worth $870,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Signet Financial Management LLC lifted its holdings in iShares Biotechnology ETF by 3.3% in the second quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock worth $326,000 after purchasing an additional 83 shares during the period. Optimum Investment Advisors lifted its holdings in iShares Biotechnology ETF by 2.6% in the second quarter. Optimum Investment Advisors now owns 3,345 shares of the financial services provider’s stock worth $423,000 after purchasing an additional 84 shares during the period. Apollon Wealth Management LLC lifted its holdings in iShares Biotechnology ETF by 1.1% in the first quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock worth $1,120,000 after purchasing an additional 96 shares during the period. SBI Securities Co. Ltd. lifted its holdings in iShares Biotechnology ETF by 5.2% in the first quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock worth $281,000 after purchasing an additional 108 shares during the period. Finally, KFG Wealth Management LLC lifted its holdings in iShares Biotechnology ETF by 4.8% in the second quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after purchasing an additional 112 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.3%

Shares of iShares Biotechnology ETF stock opened at $159.38 on Friday. The company’s 50-day moving average price is $146.78 and its two-hundred day moving average price is $134.29. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $159.79.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.